Predictive, integrative, and regulatory aspects of AI-driven computational toxicology - Highlights of the German Pharm-Tox Summit (GPTS) 2024.

Journal: Toxicology
PMID:

Abstract

The 9th German Pharm-Tox Summit (GPTS) and the 90th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) took place in Munich from March 13-15, 2024. The event brought together over 700 participants from around the world to discuss cutting-edge developments in the fields of pharmacology and toxicology as well as scientific innovations and novel insights. A key focus of the conference was on the rapidly increasing role of computational toxicology, artificial intelligence (AI), and machine learning (ML) into the field, marking a shift away from traditional methods and allowing the reduction of animal testing as primary tool for toxicological risk assessment. Tools such as Toxometris.ai showcased the potential of AI-based risk assessments for predicting carcinogenicity, offering more ethical and efficient alternatives. Additionally, computer-driven models like computer-aided pattern analysis (C@PA) for drug toxicity prediction were presented, emphasizing the growing role of chem- and bioinformatic applications in computational sciences. Throughout the summit, there was a strong focus on the need for regulatory innovation to support the adoption of these advanced technologies and ensure the safety and sustainability of chemical substances and drugs.

Authors

  • Ute Haßmann
    Toxlicon GmbH, Obwaldener Zeile 23, Berlin 12205, Germany. Electronic address: hassmann@toxlicon.com.
  • Sigrid Amann
    Toxlicon GmbH, Obwaldener Zeile 23, Berlin 12205, Germany.
  • Nelly Babayan
    Toxometris.ai Inc., USA.
  • Simone Fankhauser
    Austrian Environment Ministry, Spittelauer Lände 5, Vienna 1090, Austria.
  • Tina Hofmaier
    Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH, Spargelfeldstraße 191, Wien 1220, Austria.
  • Thomas Jakl
    Austrian Environment Ministry, Spittelauer Lände 5, Vienna 1090, Austria.
  • Monika Nendza
    Analytisches Laboratorium, Bahnhofstr. 1, Luhnstedt 24816, Germany.
  • Helga Stopper
    Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Str. 9, Würzburg 97078, Germany.
  • Sven Marcel Stefan
    Medicinal Chemistry and Systems Pharmacology, Medical Systems Biology Division, Lübeck Institute of Experimental Dermatology (LIED), University Medical Center Schleswig-Holstein (UKSH), University of Lübeck (UzL), Ratzeburger Allee 160, Lübeck 23538, Germany; Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, Lublin 20-093, Poland.
  • Robert Landsiedel
    BASF SE, Ludwigshafen am Rhein 67063, Germany.